This research evaluates the predictive value of the Scottish inflammatory prognostic score (SIPS) for major adverse cardiovascular events (MACE) in STEMI patients after primary percutaneous coronary intervention (PPCI).
Analyzed SIPS as a predictor of MACE in STEMI patients
Included patients undergoing PPCI
Evaluated long-term outcomes associated with SIPS.
SIPS is an independent predictor of long-term MACE
Utilizing SIPS may aid in early risk stratification
SIPS is presented as a cost-effective assessment tool for STEMI patients.
Abstract
SIPS is an independent predictor of long-term MACE in STEMI patients after PPCI and may serve as a simple and cost-effective tool for early risk stratification.